Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

MRNA

Moderna Inc

Dec 13 • 04:00PM ET

41.83

Dollar change -0.99
Percentage change -2.31	%

Healthcare • Biotechnology • USA • NASD

Peers: PFE BNTX NVAX JNJ AZN GSK MRK SNY LLY REGN

| Held by: VTI VOO VO QQQ VUG SPY IVV VOT XBI XLV

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-5.82	Insider Own	10.82%	Shs Outstand	385.00M	Perf Week	-5.87%
Market Cap	15.72B	Forward P/E	-	EPS next Y	-9.00	Insider Trans	-0.32%	Shs Float	343.19M	Perf Month	-0.74%
Income	-2224.00M	PEG	-	EPS next Q	-2.73	Inst Own	67.52%	Short Float	11.90%	Perf Quarter	-39.53%
Sales	5.07B	P/S	3.10	EPS this Y	23.87%	Inst Trans	-0.45%	Short Ratio	5.72	Perf Half Y	-70.13%
Book/sh	30.98	P/B	1.35	EPS next Y	4.13%	ROA	-12.62%	Short Interest	40.84M	Perf Year	-46.78%
Cash/sh	18.27	P/C	2.29	EPS next 5Y	-	ROE	-17.52%	52W Range	35.80 - 170.47	Perf YTD	-57.94%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-20.02%	ROI	-16.81%	52W High	-75.46%	Beta	1.59
Dividend TTM	-	Quick Ratio	4.20	Sales past 5Y	662.08%	Gross Margin	60.87%	52W Low	16.84%	ATR (14)	2.71
Dividend Ex-Date	-	Current Ratio	4.39	EPS Y/Y TTM	36.51%	Oper. Margin	-53.24%	RSI (14)	42.88	Volatility	6.37% 6.42%
Employees	5600	Debt/Eq	0.11	Sales Y/Y TTM	-44.06%	Profit Margin	-43.84%	Recom	2.61	Target Price	71.40
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	100.34%	Payout	-	Rel Volume	0.68	Prev Close	42.82
Sales Surprise	48.95%	EPS Surprise	101.66%	Sales Q/Q	1.69%	Earnings	Nov 07 BMO	Avg Volume	7.14M	Price	41.83
SMA20	0.48%	SMA50	-13.91%	SMA200	-54.89%	Trades		Volume	4,844,374	Change	-2.31%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97

Show Previous Ratings

Dec-13-24 08:20PM	Palantir, MicroStrategy, and Axon Enterprise To Join Nasdaq 100 (Investopedia)
08:09PM	Palantir, MicroStrategy, Axon Join Nasdaq 100; Moderna, Super Micro Get The Axe (Investor's Business Daily)
08:00PM	Annual Changes to the Nasdaq-100 Index (GlobeNewswire)
07:54PM	Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe? (Investor's Business Daily)
12:24PM	Alphabet and 9 More Stocks to Buy for 2025 (Barrons.com)
09:55AM	Loading…
09:55AM	Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter? (Investor's Business Daily)
07:12AM	FDA panel seeks more data on RSV vaccine safety in infants (BioPharma Dive)
05:00AM	The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind (CNN Business)
Dec-12-24 07:17AM	Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies (MarketWatch)
07:03AM	These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over (Motley Fool)
Dec-11-24 07:05AM	Moderna reinstated with an Underperform at BofA (TipRanks)
Dec-10-24 05:37PM	BofA downgrades Moderna, says it's 'tough time' to be vaccine maker (Yahoo Finance Video) -9.07%
05:35PM	S&P 500 Gains and Losses Today: Walgreens Pops Following Reports of Buyout Talks (Investopedia)
11:42AM	Moderna Stock Is Struggling. BofA Doesnt See Things Getting Better. (Barrons.com)
Dec-09-24 08:30AM	Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline (PR Newswire)
05:00AM	Loading…
Dec-06-24 05:00AM	Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup (Quartz)
Dec-05-24 11:25AM	Is Moderna Stock A Sell With Deep Losses Projected For The Fourth Quarter? (Investor's Business Daily)
06:45AM	Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024? (Motley Fool)
05:24AM	Moderna opens Southern Hemispheres only mRNA manufacturing facility in Victoria (Investment Monitor)
Dec-04-24 02:57PM	Moderna CEO says he'll work with Trump using 'facts and data' (Quartz)
01:26PM	Moderna CEO says he plans to work with the Trump administration using 'facts and data' (Quartz)
04:30AM	Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds (South China Morning Post)
Dec-03-24 09:34AM	Moderna shares could slump over 30% on negative CMV reading: Leerink (Investing.com)
Dec-02-24 04:11PM	Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
07:50AM	Analyst Report: Moderna, Inc. (Morningstar Research)
Nov-30-24 07:02PM	Moderna, Inc. (MRNA): A Bull Case Theory (Insider Monkey)
Nov-27-24 09:31AM	Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024? (Insider Monkey)
07:01AM	Moderna price target lowered to $45 from $59 at JPMorgan (TipRanks)
Nov-26-24 07:30AM	These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over (Motley Fool)
07:17AM	Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now (Insider Monkey)
06:47AM	Loading…
06:47AM	Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships (GuruFocus.com)
Nov-25-24 12:24PM	Top S&P 500 performers year-to-date: Vistra, Nvidia, Palantir (Yahoo Finance Video) +6.20%
07:00AM	Moderna to Present at Upcoming Conferences in December 2024 (ACCESSWIRE)
Nov-23-24 10:39AM	Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge Funds (Insider Monkey)
05:00AM	The Current 'Trump Trade' Is Less Euphoric And More Strategic (Investopedia)
Nov-22-24 05:27PM	S&P 500 Gains and Losses Today: Supermicro Stock Rallies To Finish Strong Week (Investopedia) +7.48% +6.20%
03:16PM	Jefferies says market nears short term peak RFK negativity", Vaccine makers up (Investing.com)
02:17PM	Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock (Insider Monkey)
01:32PM	Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference (Investopedia)
Nov-21-24 05:45PM	Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
03:35PM	Matt Gaetz Withdraws. Why That Might Be Bad News for RFK. (Barrons.com)
01:10PM	Is Investing in Moderna Stock (NASDAQ:MRNA) Simply Dead Money? (TipRanks)
Nov-20-24 08:00AM	Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies (PR Newswire)
06:30AM	Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer (PR Newswire)
05:00AM	Moderna initiated with a Hold at Berenberg (TipRanks)
Nov-19-24 04:30PM	S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing (Investopedia) -5.62%
06:30AM	HSBC upgrades Moderna to Buy on pipeline potential (TipRanks)
Nov-18-24 06:38PM	Asian Stocks Set to Track US Higher as Bonds Gain: Markets Wrap (Bloomberg) +7.22%
04:51PM	S&P 500 Gains and Losses Today: Uber Falls as Trump Eyes Looser Self-Driving Rules (Investopedia)
01:24PM	Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination (Benzinga)
11:21AM	Cramer's Mad Dash: Moderna gets upgrade from HSBC (CNBC TV)
10:57AM	Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential (Investing.com)
12:47AM	Analyst Report: Moderna, Inc. (Morningstar Research)
Nov-15-24 05:14PM	S&P 500 Gains and Losses Today: Palantir Stock Jumps as Listing Heads to Nasdaq (Investopedia) -7.34%
04:19PM	Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
04:18PM	How analysts are reacting to RFK Jr. as Trump's HHS pick (Yahoo Finance Video)
12:24PM	Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now (Insider Monkey)
12:04PM	Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
10:46AM	Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick (Yahoo Finance Video)
09:43AM	Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of. (Yahoo Finance)
09:34AM	Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too (The Wall Street Journal)
09:34AM	Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary (FastCompany)
08:22AM	Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary (Quartz)
08:08AM	Trumps RFK Jr. Pick Weighs on Vaccine Makers (The Wall Street Journal)
06:45AM	RFK Jr. News Hits Global Pharma Stocks (The Wall Street Journal)
05:21AM	Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide. (Barrons.com)
Nov-14-24 04:28PM	Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official (Yahoo Finance) -5.62%
12:25PM	Is Moderna Stock A Sell After A Key Nuance Undercut Its Third-Quarter Beat? (Investor's Business Daily)
Nov-13-24 07:23PM	The Oncology Bet Is Already Paying Off For Pfizer (Benzinga)
08:00AM	Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio (PR Newswire)
08:00AM	Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner (PR Newswire)
Nov-12-24 02:43PM	Novavax: Stock plunges after quarterly earnings, but sees hope in licensing deals (Yahoo Finance)
02:43PM	Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals (Yahoo Finance)
12:52PM	FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine (Pharmaceutical Technology)
08:15AM	Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year (ACCESSWIRE)
Nov-11-24 04:32PM	S&P 500 Gains and Losses Today: Index Closes Above 6,000 on Post-Election Rally (Investopedia) -8.71%
06:42AM	Modernas mRESVIA vaccine gains Health Canada approval (Pharmaceutical Technology)
Nov-08-24 01:47PM	Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn (Benzinga) -6.86%
10:00AM	2 Biotech Stocks You Can Buy Hand Over Fist This Month (Motley Fool)
09:30AM	Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:30AM	Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older (ACCESSWIRE)
07:30AM	Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma (PR Newswire)
02:10AM	Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ... (GuruFocus.com)
Nov-07-24 04:02PM	Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat' (Investor's Business Daily)
03:25PM	Analyst Report: Moderna, Inc. (Morningstar Research)
02:45PM	Moderna (MRNA) Q3 2024 Earnings Call Transcript (Motley Fool)
11:56AM	Moderna Stock Rises on Surprise Q3 Profit (Investopedia)
10:15AM	2025 will be 'fairly challenging year' for Moderna: Analyst (Yahoo Finance Video)
09:38AM	Moderna Stock Gains on Better-Than-Expected Covid-19 Vaccine Sales (The Wall Street Journal)
09:34AM	Moderna Sales Get Lift From Early Nod for Newest Covid Shot (Bloomberg)
08:58AM	Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook (Investor's Business Daily)
08:57AM	Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales (The Wall Street Journal)
08:26AM	Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold (CNBC TV)
07:40AM	Moderna (MRNA) Q3 Earnings and Revenues Surpass Estimates (Zacks)
07:09AM	Moderna shares surge after vaccine maker posts unexpected third-quarter profit (Investing.com)
06:53AM	Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. (Barrons.com)
06:41AM	Moderna: Q3 Earnings Snapshot (Associated Press Finance)
06:33AM	Moderna reports surprise profit on higher-than-expected COVID vaccine sales (Reuters)
06:30AM	Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? (Investor's Business Daily)
06:30AM	Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates (ACCESSWIRE)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM
AFEYAN NOUBAR	Director	Mar 13 '24	Sale	108.54	15,000	1,628,031	2,131,931	Mar 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08 '24	Sale	99.05	544	53,884	9,267	Mar 11 09:05 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 04 '24	Sale	94.34	117	11,038	8,673	Mar 05 05:56 PM
Hoge Stephen	President	Mar 04 '24	Sale	94.34	309	29,151	1,516,241	Mar 05 05:52 PM
Mock James M	Chief Financial Officer	Feb 29 '24	Sale	94.57	647	61,188	4,300	Mar 01 05:33 PM
Klinger Shannon Thyme	Chief Legal Officer	Feb 29 '24	Sale	94.57	670	63,363	8,557	Mar 01 05:29 PM
Hoge Stephen	President	Feb 29 '24	Sale	94.57	2,388	225,838	1,515,898	Mar 01 05:25 PM
Hoge Stephen	President	Feb 22 '24	Sale	100.00	15,000	1,500,000	1,513,433	Feb 23 04:04 PM
Hoge Stephen	President	Feb 16 '24	Sale	88.88	10,542	936,981	1,528,433	Feb 16 04:19 PM
Bancel Stephane	Chief Executive Officer	Feb 16 '24	Sale	88.88	26,351	2,342,098	5,460,224	Feb 16 04:10 PM
Hoge Stephen	President	Feb 12 '24	Sale	86.23	304	26,214	1,516,281	Feb 13 04:13 PM
Hoge Stephen	President	Jan 16 '24	Sale	103.90	15,000	1,558,500	1,516,063	Jan 17 04:12 PM
Mock James M	Chief Financial Officer	Jan 08 '24	Sale	109.75	772	84,731	3,632	Jan 09 04:08 PM
Hoge Stephen	President	Dec 27 '23	Sale	100.01	45,000	4,500,450	1,531,063	Dec 28 08:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience